Kenneth Rosenfield

My name is Mats-Ola Eriksson. I'm an interventional radiologist at Mälarsjukhuset Hospital in Eskilstuna, Sweden. I graduated from Uppsala University in 1997 and specialized in radiology and since 2005 subspecialized in interventional radiology, initially at Uppsala Univerity Hospital, but since 2013 and after writing my doctoral thesis on aortic dissections and intravascular ultrasound, at Mälarsjukhuset Hospital. I currently work as Deputy Clinic manager and Chief interventional radiologist. Our intitution hosts 2 state of the art interventional hybrid cath labs and we perform a broad variety of interventional procedures, ranging from vascular- and general surgery to interventional oncology, urology and gynecology. I also participate in different educational groups regarding radiation protection and justification for the use of radiological examinations.
I've always been interested in sports and competed on the Swedish national team in Triathlon during a few years before med school. I also competed in cycling at national elite level. In recent years I've switched to powerlifting and recreational endurance training. Besides spending time with my family, I enjoy music, both writing- and playing, especially the piano.

Dr. Rosenfield is an interventional cardiologist and vascular specialist performing complex cardiac and vascular interventions. He is Section Head for Vascular Medicine and Intervention in the Division of Cardiology at Massachusetts General Hospital. He earned a masters degree in Health Care Delivery Science from Dartmouth College. In addition to being a master clinician and interventionalist, Dr. Rosenfield has dedicated much of his career to educating fellows, residents, students, and colleagues. He is the recipient of the distinguished Laennec award for his outstanding teaching and mentorship. He is also a researcher and clinical trialist. He designed and served as national principle investigator for several landmark studies, including Aspire 2, Levant 2, Superb, ACT 1, and NIH BEST-CLI trial. He is a leader in the cardiovascular world, having been elected to the Board of Governors of American College of Cardiology, immediate past-President of the MA ACC Chapter, and immediate past-President of the Society for Cardiovascular Angiography and Interventions (SCAI). Dr. Rosenfield is a founding member of VIVA, a 501c3 organization, and sits on its board of directors. At Massachusetts General Hospital, he is the Medical director of the PERT Program, which he founded with his colleagues; he also founded the National PERT Consortium, a 501c3 organization dedicated to improving management, outcomes, and awareness of Pulmonary Embolism, and he served as its initial President; he remains a member of the PERT Consortium Executive Committee.

Dr Bella Hausen obtained her medical degree from the universities of Manchester and Edinburgh where she was initially a plastic surgical trainee with an interest in micro vascular repair. She completed advance microsurgical training at Zurich, and Rhainoplasty Msc at Barcelona. She went on to complete her Radiology and Interventional Radiology specialist registration with the royal college of Radiology London U.K. She completed her advance Endovascular fellowship with Professor Andrew Holden at Auckland University hospital, NewZealand.

Dr Hausen preformed the first lithotripsy in peripheral endovascular CLI disease, along with the first Sirolimus DCB use in both CLI and AVF, in Europe.

Dr Huasen is the head of endovascular research and innovation in Lancashire U.K. Her current interest are training and education of future doctors, radiation protection for patients and staff, CLI management, AVF salvage, pain management and women’s health. She currently works at Lancashire University health trusts U.K.